Westfall Edward, Fridirici Zachary, El-Kouri Nadeem, McSpadden Ryan, Loochtan Mike, Stankiewicz James
Loyola University Medical Center, Maywood, IL, USA.
Loyola University Chicago, Stritch School of Medicine, IL, USA.
Ear Nose Throat J. 2023 Sep;102(9):573-579. doi: 10.1177/01455613211015438. Epub 2021 Jun 6.
The orbital complication rate during endoscopic sinus surgery (ESS) is <1%. Orbital fat exposure during ESS can herald orbital complications including orbital hematoma, extraocular muscle trauma, optic nerve injury, or blindness. The objective of this study was to evaluate the current consensus regarding diagnosis and management of orbital fat exposure during ESS.
A 24-point survey focused on orbital fat exposure during ESS was distributed to American Rhinologic Society members. Also, a retrospective review of 25 cases of orbital fat exposure drawn from the principal investigator's 30-year experience was performed.
Over 10 000 surgical cases of the principal investigator were reviewed. Twenty-five patients had orbital fat exposure. Five developed minor complications while 2 were major (ie, temporary vision changes). Two hundred thirty-six surgeons responded to the survey; 93% had encountered orbital fat during ESS; 88% of surgeons identify orbital fat by either its appearance endoscopically or the "bulb press" test. Almost every responding surgeon will cautiously avoid further manipulation in the area of orbital fat exposure. Nearly half will immediately curtail the extent of surgery. Surgeons do not significantly change postoperative management. Considerations regarding observation in postanesthesia care unit, close follow-up, and strict nose blowing precautions are common.
Orbital fat exposure during ESS is a rarely discussed, but clinically important. Orbital fat exposure can be a harbinger for major orbital complications that should be recognized by endoscopic appearance and confirmed with the bulb press test. Caution with "no further manipulation" of orbital fat is the guiding principle for intraoperative management, while postoperative management is generally expectant.Level 4 Evidence.
鼻内镜鼻窦手术(ESS)期间眼眶并发症发生率<1%。ESS期间眼眶脂肪暴露可能预示眼眶并发症,包括眼眶血肿、眼外肌损伤、视神经损伤或失明。本研究的目的是评估当前关于ESS期间眼眶脂肪暴露的诊断和处理的共识。
向美国鼻科学会成员发放了一份关于ESS期间眼眶脂肪暴露的24项调查问卷。此外,对主要研究者30年经验中25例眼眶脂肪暴露病例进行了回顾性分析。
回顾了主要研究者超过10000例手术病例。25例患者出现眼眶脂肪暴露。5例发生轻微并发症,2例发生严重并发症(即短暂视力改变)。236名外科医生回复了调查问卷;93%在ESS期间遇到过眼眶脂肪;88%的外科医生通过内镜下外观或“眼球按压”试验识别眼眶脂肪。几乎每位回复的外科医生都会谨慎避免在眼眶脂肪暴露区域进一步操作。近一半医生会立即缩减手术范围。外科医生术后处理无显著变化。在麻醉后护理单元进行观察、密切随访以及严格的擤鼻预防措施是常见的考虑因素。
ESS期间眼眶脂肪暴露很少被讨论,但具有临床重要性。眼眶脂肪暴露可能是严重眼眶并发症的先兆,应通过内镜外观识别并用眼球按压试验确认。对眼眶脂肪“不再进一步操作”的谨慎态度是术中处理的指导原则,而术后处理通常是观察等待。证据等级:4级。